Search Results

There are 12231 results for: content related to: Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia

  1. You have full text access to this OnlineOpen article
    Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia


    Volume 117, Issue 21, 1 November 2011, Pages: 4831–4868, Meir Wetzler, Chris Andrews, Laurie A. Ford, Sheila Tighe, Maurice Barcos, Sheila N. J. Sait, AnneMarie W. Block, Norma J. Nowak, Maria R. Baer, Eunice S. Wang and Heinz Baumann

    Article first published online : 31 MAR 2011, DOI: 10.1002/cncr.26097

  2. You have full text access to this OnlineOpen article
    Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG-9500)

    American Journal of Hematology

    Volume 82, Issue 12, December 2007, Pages: 1056–1062, Stephen H. Petersdorf, Cathryn Rankin, David R. Head, Howard R. Terebelo, Cheryl L. Willman, Stanley P. Balcerzak, Anand B. Karnad, Shaker R. Dakhil and Frederick R. Appelbaum

    Article first published online : 15 AUG 2007, DOI: 10.1002/ajh.20994

  3. Effective salvage therapy for high-risk relapsed or refractory acute myeloid leukaemia with cisplatin in combination with high-dose cytarabine and etoposide

    European Journal of Haematology

    Yun-Gyoo Lee, Ji-hyun Kwon, Inho Kim, Sung Soo Yoon, Jong-Seok Lee and Seongyang Park

    Article first published online : 27 MAR 2014, DOI: 10.1111/ejh.12274

  4. You have full text access to this OnlineOpen article
    Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses

    British Journal of Haematology

    Volume 149, Issue 3, May 2010, Pages: 399–409, Ursula Creutzig, Martin Zimmermann, Michael Dworzak, Christian Urban, Günter Henze, Bernhard Kremens, Max Lakomek, Jean-Pierre Bourquin, Jan Stary and Dirk Reinhardt

    Article first published online : 8 MAR 2010, DOI: 10.1111/j.1365-2141.2010.08107.x

  5. A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia

    British Journal of Haematology

    Volume 81, Issue 2, June 1992, Pages: 170–177, Gary Schiller, James Gajewski, Stephen Nimer, Mary Territo, Winston Ho, Myung Lee and Richard Champlin

    Article first published online : 12 MAR 2008, DOI: 10.1111/j.1365-2141.1992.tb08203.x


    Australian and New Zealand Journal of Medicine

    Volume 15, Issue 1, February 1985, Pages: 10–15, P. C. VINCENT, M. BUCK, G. A. R. YOUNG and W. J. BENSON

    Article first published online : 25 MAR 2008, DOI: 10.1111/j.1445-5994.1985.tb02722.x

  7. You have full text access to this OnlineOpen article
    Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin) ± rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma


    Volume 116, Issue 19, 1 October 2010, Pages: 4573–4579, Luigi Rigacci, Alberto Fabbri, Benedetta Puccini, Ida Chitarrelli, Annalisa Chiappella, Umberto Vitolo, Alessandro Levis, Francesco Lauria and Alberto Bosi

    Article first published online : 19 AUG 2010, DOI: 10.1002/cncr.25216

  8. You have full text access to this OnlineOpen article
    Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients

    American Journal of Hematology

    Volume 87, Issue 12, December 2012, Pages: 1047–1051, Barbara Scappini, Giacomo Gianfaldoni, Francesco Caracciolo, Francesco Mannelli, Caterina Biagiotti, Claudio Romani, Enrico M. Pogliani, Federico Simonetti, Lorenza Borin, Rosa Fanci, Ilaria Cutini, Giovanni Longo, Maria Chiara Susini, Emanuele Angelucci and Alberto Bosi

    Article first published online : 1 AUG 2012, DOI: 10.1002/ajh.23308

  9. Hematologic remission and cytogenetic improvement after treatment of stable-phase chronic myelogenous leukemia with continuous infusion of low-dose cytarabine

    American Journal of Hematology

    Volume 43, Issue 2, June 1993, Pages: 95–102, Michael J. Robertson, Ramana Tantravahi, James D. Griffin, George P. Canellos and Dr. Stephen A. Cannistra

    Article first published online : 11 JUL 2006, DOI: 10.1002/ajh.2830430205

  10. You have full text access to this OnlineOpen article
    Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia

    American Journal of Hematology

    Volume 84, Issue 7, July 2009, Pages: 422–427, Jiazhuo Liu, Yingchang Mi, Mingwei Fu, Wenjuan Yu, Ying Wang, Dong Lin, Shougeng Bian and Jianxiang Wang

    Article first published online : 16 APR 2009, DOI: 10.1002/ajh.21441

  11. Induction Therapy of Acute Myeloid Leukemia

    Leukemias: Principles and Practice of Therapy

    Martha Wadleigh, Daniel J. Deangelo, Pages: 125–137, 2011

    Published Online : 4 JAN 2011, DOI: 10.1002/9781444327359.ch10

  12. New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: Cancer and leukemia group B 8461

    Genes, Chromosomes and Cancer

    Volume 52, Issue 4, April 2013, Pages: 385–401, Alison Walker, Krzysztof Mrózek, Jessica Kohlschmidt, Kathleen W. Rao, Mark J. Pettenati, Lisa J. Sterling, Guido Marcucci, Andrew J. Carroll, Clara D. Bloomfield and for the Alliance for Clinical Trials in Oncology

    Article first published online : 10 DEC 2012, DOI: 10.1002/gcc.22036

  13. You have full text access to this OnlineOpen article
    Primary refractory acute myeloid leukaemia – in search of better definitions and therapies

    British Journal of Haematology

    Volume 155, Issue 4, November 2011, Pages: 413–419, Farhad Ravandi

    Article first published online : 13 SEP 2011, DOI: 10.1111/j.1365-2141.2011.08869.x

  14. You have full text access to this OnlineOpen article
    Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients


    Volume 118, Issue 18, 15 September 2012, Pages: 4471–4477, Stefan Faderl, Farhad Ravandi, Xuelin Huang, Xuemei Wang, Elias Jabbour, Guillermo Garcia-Manero, Tapan Kadia, Alessandra Ferrajoli, Marina Konopleva, Gautam Borthakur, Jan Burger, Jennie Feliu and Hagop M. Kantarjian

    Article first published online : 26 JAN 2012, DOI: 10.1002/cncr.27429

  15. You have full text access to this OnlineOpen article
    Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with acute myeloid leukemia

    American Journal of Hematology

    Volume 82, Issue 4, April 2007, Pages: 304–306, Bungo Saito, Tsuyoshi Nakamaki, Hidetoshi Nakashima, Takako Usui, Norimichi Hattori, Keiichiro Kawakami and Shigeru Tomoyasu

    Article first published online : 31 AUG 2006, DOI: 10.1002/ajh.20772

  16. High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine

    Pediatric Blood & Cancer

    Volume 60, Issue 7, July 2013, Pages: 1154–1160, Katrine Helle Johannsen, Mette Møller Handrup, Birgitte Lausen, Dr. Henrik Schrøder and Prof. Henrik Hasle

    Article first published online : 31 DEC 2012, DOI: 10.1002/pbc.24448

  17. You have full text access to this OnlineOpen article
    High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years


    Volume 118, Issue 2, 15 January 2012, Pages: 428–433, Martha Arellano, Elliott Winton, Lin Pan, Lisa Lima, Mourad Tighiouart, Kapil Bhalla, Leonard T. Heffner, Jessica Neely, Donald Hutcherson, Morgan McLemore, Amelia Langston and H. Jean Khoury

    Article first published online : 29 JUN 2011, DOI: 10.1002/cncr.26290

  18. Continuous and high-dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: Report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study

    Pediatric Blood & Cancer

    Volume 57, Issue 1, 15 July 2011, Pages: 36–40, Takashi Taga, Yasuto Shimomura, Yasuo Horikoshi, Atsushi Ogawa, Masaki Itoh, Masahiko Okada, Junichi Ueyama, Takeshi Higa, Arata Watanabe, Hirokazu Kanegane, Asayuki Iwai, Yutaka Saiwakawa, Kazuhiro Kogawa, Junko Yamanaka and Masahito Tsurusawa

    Article first published online : 30 DEC 2010, DOI: 10.1002/pbc.22943

  19. You have full text access to this OnlineOpen article
    Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine


    Volume 117, Issue 5, 1 March 2011, Pages: 974–981, Thomas Prebet, Anne Etienne, Raynier Devillier, Emilie Romeo, Aude Charbonnier, Evelyne D'incan, Benjamin Esterni, Christine Arnoulet, Didier Blaise and Norbert Vey

    Article first published online : 18 OCT 2010, DOI: 10.1002/cncr.25554

  20. You have full text access to this OnlineOpen article
    Acute pancreatitis associated with continuous infusion cytarabine therapy: A case report


    Volume 77, Issue 12, 15 June 1996, Pages: 2588–2591, Charles E. McBride, Robert T. Yavorski, Frank M. Moses, Mark E. Robson, Dominic A. Solimando Jr. and John C. Byrd

    Article first published online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0142(19960615)77:12<2588::AID-CNCR24>3.0.CO;2-N